Analysts/Institutional Investor Meet/Con. Call Updates

Ref: HNL/SEC/2026-27/23 Date: 18th August 2026 National Stock Exchange of India Limited BSE Limited Listing & Compliance Department Listing Department Exchange Plaza, C-1, Block G, Floor 25, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400001 Mumbai – 400051, Maharashtra, India. Maharashtra, India. SYMBOL: HEXAGON Scrip Code: 544785 Dear Sir/Madam, Ref: HEXAGON NUTRITION LIMITED - ISIN: INE0JUI01012 Subject: Disclosure Under Regulation 30 Of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) – Q1 (FY 2026-27) Earnings Call Transcript Pursuant to the provisions of Regulation 30 of Listing Regulations, please find enclosed transcript of the Earnings Conference Call held on August 14, 2026, for Un-audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The transcript is also being disseminated on the Company's website at www.hexagonnutrition.com This is for your information and records. Yours faithfully, For Hexagon Nutrition Limited Vedanti Vartak Company Secretary and Compliance Officer ICSI Membership No.: A41580 “Hexagon Nutrition Limited Q1 FY27 Earnings Conference Call” August 14, 2026 MANAGEMENT: DR. NIKHIL KELKAR – JOINT MANAGING DIRECTOR – HEXAGON NUTRITION LIMITED MR. VIKRAM KELKAR – MANAGING DIRECTOR – HEXAGON NUTRITION LIMITED MR. SOMAN JANA – CHIEF FINANCIAL OFFICER – HEXAGON NUTRITION LIMITED Page 1 of 18 Hexagon Nutrition Limited August 14, 2026 Moderator: Ladies and gentlemen, good day and welcome to the Q1 FY '27 Earnings Conference Call of Hexagon Nutrition Limited. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing star then zero on your touch-tone phone. Please note that this conference is being recorded. I now hand the conference over to Dr. Nikhil Kelkar, Joint Managing Director. Thank you, and over to you, sir. Nikhil Kelkar: Good evening, everyone. Am I audible to all -- I hope I am audible to all of you. A very, very warm welcome to all our shareholders, analysts, institutional investors, member of the investment community, and everyone joining us today for Hexagon Nutrition Limited's Q1 FY '27 earnings conference call. This quarter marks an important milestone for us as it's our first quarterly results announcement following our successful listing on the BSE and the NSE in June 2026. On behalf of the entire management team, I would like to thank our shareholders, customers, employees, partners, and all our stakeholders for their continued confidence and support. We are pleased to have started FY '27 on a very strong note with a healthy year-on-year growth in both revenue and profitability. For the quarter one of FY '27, our consolidated revenue from operations stood at INR104.3 crores, registering a growth of 43.2% comparing with INR72.9 crores in Q1 of FY '26. Our EBITDA stood at INR11.8 crores, representing a year-on-year growth of 17.3%, while profit after-tax stood at INR8.1 crore, registering a growth of 25.1% over the corresponding quarter of the previous year. We believe this performance reflects the continued demand for our nutrition solutions and the progress we are making across our domestic and international markets. Let me briefly touch upon the broader opportunity that we see for the business. Nutrition is increasingly becoming an integral part of healthcare and wellness. Rising awareness around preventive healthcare, balanced nutrition, immunity, active lifestyles, and specialized nutrition requirements is creating a structural opportunity for this industry. At Hexagon Nutrition, our diversified portfolio enables us to participate across multiple segments of this opportunity. Our business spans micronutrient premixes, clinical nutrition, therapeutic nutrition, food fortification, and consumer nutrition. This diversification gives us the ability to serve customers across different applications and markets. Our focus continues to remain on building a diversified and scalable nutrition platform. Research and development remains at the core of our business. We continue to invest in developing innovative formulations and nutrition solutions that address evolving customer and healthcare requirements. Page 2 of 18 Hexagon Nutrition Limited August 14, 2026 At the same time, our manufacturing facilities provide us with a strong foundation to serve both domestic and international customers while maintaining our focus on quality, consistency, and operational efficiency. Our international presence is another pillar of our growth strategy. We currently serve customers across more than 70 countries, giving us a diversified geographical footprint and opportunities to further expand our presence in the international markets. We also continue to see significant potential in our clinical and functional nutrition businesses as consumer awareness around specialized nutrition continues to increase. As we move through FY '27, our priorities remain focused on sustainable revenue growth, strengthening our international presence, innovation-led product development, operational efficiencies, and disciplined capital allocation. We believe the structural drivers supporting the nutrition industry remain strong, and our diversified portfolio, R&D capabilities, manufacturing infrastructure, and customer relationships position us well to participate in these opportunities. With that, I would like to now hand over the call to our Managing Director, Mr. Vikram Kelkar, who will take you through the operational performance and key business initiatives during the quarter. Thank you. Vikram Kelkar: Thank you, Dr. Nikhil. Good evening, everyone. Let me take you through the operational performance and key developments across our businesses during the quarter. As Dr. Nikhil mentioned, we have started FY '27 with strong revenue momentum. Our diversified business model remains central to our strategy, with our operations spanning micronutrient premixes, clinical and wellness nutrition, therapeutic nutrition, and food fortification. Let me begin with our micronutrient premix business. Premixes continue to be an important growth engine for Hexagon Nutrition. We work with the customers across food, pharmaceutical, and other industries, providing customized blends of vitamins, minerals, and other nutritional ingredients. We continue to see structural opportunities in this business, driven by increasing awareness around nutrition and fortification as well as the growing adoption of fortified food products. The increasing focus on nutritional security and fortification, both in India and globally, provides a favorable environment for organized players with strong formulation, manufacturing, and quality capabilities. Coming to our clinical and wellness nutrition business, our PentaSure franchise continues to be an important part of our branded nutrition portfolio. We see significant headroom for growth in the clinical nutrition and wellness market, and we are continuing to strengthen our presence through our sales and distribution network. We are also focusing on increasing the penetration of our other branded products, especially PediaGold and Obesigo. Page 3 of 18 Hexagon Nutrition Limited August 14, 2026 As discussed during our previous earnings interaction, we are expanding our reach beyond Tier 1 markets and increasing our presence in Tier 2 and Tier 3 cities. This expansion is being supported by strengthening our sales force and distribution network. We are also working towards increasing our presence across e-commerce, e-pharmacy, and digital channels, alongside our medical marketing initiatives. We believe these initiatives will help us to improve our brand awareness, increase consumer reach, and build our bran [Showing first 8,000 characters — download PDF for full document]